文献速递中医内科中药与中成药合理使用

圣惠汤经Nrf2/HO-1与NF-κB通路减轻AlCl3诱导斑马鱼阿尔茨海默病模型氧化应激与神经炎症

ShengHui Decoction mitigates oxidative stress and neuroinflammation in AlCl3-induced AD zebrafish via activating Nrf2/HO-1 and inhibiting NF-κB signaling pathway.
PubMed 文献 · J Ethnopharmacol · 2025-11-03

该研究以AlCl3诱导的斑马鱼AD模型为对象,用UPLC-MS/MS鉴定圣惠汤成分,并给予0.74、1.48、2.96 mg/mL三个浓度进行行为学、组织病理学及生化检测。结果显示圣惠汤改善认知缺陷与病理改变,通过上调Nrf2、HO-1、NQO1及下调NF-κB p65、p-NF-κB p65、NLRP3和促炎因子发挥抗氧化与抗炎作用。

要点

  • 圣惠汤可改善AlCl3诱导斑马鱼AD模型的认知缺陷与组织病理异常。
  • 圣惠汤通过激活Nrf2/HO-1轴并抑制NF-κB信号通路发挥抗氧化和抗炎作用。
  • 研究为圣惠汤治疗AD提供了实验依据,并佐证中医补肾填精治则。

核心结论

  • 圣惠汤有效改善AlCl3诱导斑马鱼AD模型的认知表现并减少AD样病理损伤。
  • 圣惠汤通过激活Nrf2/HO-1轴和抑制NF-κB信号通路发挥抗氧化与抗炎活性,减轻氧化应激和神经炎症反应。
  • 研究结果为圣惠汤作为AD潜在治疗药物提供了实验证据,并佐证中医补肾填精治疗AD的原则。

研究设计与样本

  • 研究采用AlCl3诱导的斑马鱼AD模型,并以0.74、1.48、2.96 mg/mL三个浓度的圣惠汤进行干预。
  • 采用UPLC-MS/MS鉴定圣惠汤的生物活性成分,并通过行为学测试和组织病理学分析评估其对凋亡和Aβ沉积的影响。
  • 采用生化检测和酶联免疫吸附试验定量SOD、MDA、GSH-Px、TNF-α、IL-6、IL-1β和IL-18,并用蛋白质印迹法检测Nrf2、HO-1、NQO1、NF-κB p65、p-NF-κB p65和NLRP3的蛋白表达。

主要发现

  • UPLC-MS/MS分析鉴定圣惠汤主要成分为酚酸类、皂苷类、木脂素/香豆素类、黄酮类和脂肪醇类。
  • 圣惠汤显著改善AlCl3诱导斑马鱼的认知缺陷和组织病理学异常。
  • 圣惠汤通过上调Nrf2、HO-1和NQO1表达减轻氧化应激,同时下调AlCl3诱导的NF-κB p65、p-NF-κB p65、NLRP3和促炎因子水平。

临床怎么用

  • 圣惠汤在AlCl3诱导斑马鱼AD模型中显示出改善认知和AD样病理的潜力,为其临床用于AD提供了实验依据。
  • 其作用机制涉及激活Nrf2/HO-1轴和抑制NF-κB信号通路,可作为AD氧化应激与神经炎症干预的候选方剂。
  • 研究结果佐证了中医补肾填精原则在AD治疗中的应用,支持进一步开展临床转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: ShengHui decoction (SHD), a traditional Chinese herbal formula, has long been used clinically to mitigate Alzheimer's disease (AD), demonstrating significant efficacy in alleviating cognitive impairment. However, its molecular mechanisms remain insufficiently understood. AIM OF THE STUDY: To clarify the effects of SHD on oxidative stress-related markers and inflammatory cytokines in an aluminum chloride (AlCl3)-induced zebrafish model of AD and as well as uncover its underlying mechanisms in alleviating oxidative stress and neuroinflammation. MATERIALS AND METHODS: Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was employed to identify the bioactive constituents of SHD. Behavioral tests and histopathological analyses were then conducted to evaluate the effects of SHD (0.74, 1.48, and 2.96 mg/mL) on apoptosis and amyloid-beta (Aβ) deposition in an AlCl3-induced AD zebrafish model. Biochemical assays and enzyme-linked immunosorbent assay were used to quantify superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), IL-1 beta (IL-1β), and IL-18. Western blot analysis was performed to determine the protein expression of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1), nuclear factor-kappa B p65 (NF-κB p65), phosphorylated NF-κB p65 (p-NF-κB p65), and NOD-like receptor family pyrin domain containing 3 (NLRP3). RESULTS: UPLC-MS/MS profiling identified phenolic acids, saponins, lignans/coumarins, flavonoids, and aliphatic alcohols as the main constituents of SHD. SHD significantly ameliorated cognitive deficits and histopathological abnormalities in AlCl3-induced zebrafish. Moreover, SHD attenuated oxidative stress by upregulating Nrf2, HO-1, and NQO1 expression, while downregulating AlCl3-induced levels of NF-κB p65, p-NF-κB p65, NLRP3 and pro-inflammatory factors. CONCLUSIONS: SHD effectively improved cognitive performance and reduced AD-like pathological lesions in AlCl3-induced zebrafish. Importantly, SHD exhibits both antioxidant and anti-inflammatory activities by activating the Nrf2/HO-1 axis and inhibiting NF-κB signaling, thereby alleviating oxidative stress and neuroinflammatory responses in AD. These findings provide experimental evidence supporting SHD as a potential therapeutic agent for AD, and substantiate the traditional Chinese medicine principle of tonifying the kidney and replenishing essence in the treatment of AD.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Kong M, Xu Z, Lu H, et al. ShengHui Decoction mitigates oxidative stress and neuroinflammation in AlCl3-induced AD zebrafish via activating Nrf2/HO-1 and inhibiting NF-κB signaling pathway. J Ethnopharmacol. 2025. PMID: 41192695. doi:10.1016/j.jep.2025.120785

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。